Who can be affected by IgA Nephropathy?
How common is IgA Nephropathy?
IgA Nephropathy is a rare disease, but the most common form of glomerulonephritis. The worldwide incidence is estimated to be at least 2.5 cases per 100,000 of the population.1 Prevalence varies by geographical region and ethnic origin. Although there are no standardised international biopsy guidelines, biopsy and dialysis registers show that the incidence rates of IgA Nephropathy tend to be higher in Asiatic countries.2
2,5/100.000
individuals worldwide develop IgAN every year.1
Learn more about the worldwide prevalence of IgA Nephropathy.*
* Frequency of cases of IgAN among glomerular diseases diagnosed by means of biopsy. Adapted from: O’Shaughnessy MM et al. (2018).3
Is everybody equally at risk of developing IgAN?
Individuals of any age can develop IgA Nephropathy. However, this form of glomerulonephritis occurs most frequently in persons in their late teens to their late 30s. Men are at greater risk of developing IgAN; statistics show that they suffer from the disease on average twice as frequently as women.3, 4
Learn more about IgAN
Referenzen
- McGrogan A et al. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant 2011; 26(2): 414–430.
- Rodrigues JC, Haas M, Reich HN. IgA Nephropathy. Clin J Am Soc Nephrol 2017; 12(4): 677–686.
- O’Shaughnessy MM et al. Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey. Nephrol Dial Tranplant 2018; 33(4): 661–669.
- National Institute of Diabetes and Digestive and Kidney Diseases. IgA Nephropathy, under: Https://www.niddk.nih.gov/health-information/kidney-disease/iga-nephropathy (last accessed: February 2022).
- Thaiss F, Stahl RAK. IgA-Nephropathie. Klinik, Pathogenese und Therapie der häufigsten Glomerulonephritis. Dt Ärztebl 2000; 97(41): A 2708–2711.
- Medscape.com. Pediatric IgA Nephropathy, under: https://emedicine.medscape.com/article/981516-overview (last accessed: February 2022).